IPP Bureau
Granules Pharmaceuticals clears USFDA audit
By IPP Bureau - March 15, 2022
This is the sixth successful USFDA audit for this facility
Live Pharma Coalition to organise its first-ever conclave in Mumbai
By IPP Bureau - March 15, 2022
The focus is to build collaborative learning and sharing ecosystem
IHH Healthcare India appoints Biju Nair as COO of Bengaluru cluster
By IPP Bureau - March 15, 2022
He has over 25 years of rich experience in marketing and business in various sectors
UST launches new digital patient engagement solution in partnership with Well-Beat
By IPP Bureau - March 15, 2022
The new solution, built on patented blockchain technology, dynamically adapts to patients' behaviour patterns to make clinical encounters more effective
Exergen Medical expands presence in India
By IPP Bureau - March 15, 2022
The TAT-5000 and the TAT-2000 thermometers for professional use by doctors and nurses and the TAT-2000C thermometer for consumer applications are based on a very innovative infrared technology
Illumina unveils pathbreaking genomic profiling test for cancer in Europe
By IPP Bureau - March 15, 2022
The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey
Spectrum Chemical launches products for vaccines, therapeutics and biopharmaceuticals
By IPP Bureau - March 15, 2022
A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing
AbbVie and Scripps Research plan to develop anti-viral for Covid-19
By IPP Bureau - March 15, 2022
The initial SARS-CoV-2 research program at Calibr, the drug discovery and development division of Scripps Research, was supported by funding from the Bill & Melinda Gates Foundation
Zolgensma used pre-symptomatically enables kids to stand and walk
By IPP Bureau - March 14, 2022
Novartis data again demonstrate age-appropriate development when Zolgensma is used presymptomatically, and post-hoc data reveal SMA Type 1 patients could speak, swallow and maintain airway protection
Ascletis increases ritonavir production capacity to 530 million tablets a year
By IPP Bureau - March 14, 2022
Ritonavir oral tablet is a pharmacokinetic booster of multiple oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid (Nirmatrelvir 300 mg tablet + ritonavir 100 mg tablet co-administration package)
Draft policy on medical devices released
By IPP Bureau - March 14, 2022
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
Roche Diagnostics India wins Frost & Sullivan 2021 India leadership award
By IPP Bureau - March 14, 2022
Its technology-centric solutions enable hospitals to enhance operational efficiency and enable faster clinical decision making
USFDA approves Zydus’ Colestipol Hydrochloride tablets
By IPP Bureau - March 14, 2022
It is only the second generic application approved by the USFDA
Alembic receives USFDA tentative approval for hypertension drug
By IPP Bureau - March 14, 2022
Macitentan tablets, 10 mg have an estimated market size of US $ 797 million for twelve months ending Dec 2021 according to IQVIA
SPAG appoints Ritika Jauhari as President- Strategy & New Business
By IPP Bureau - March 14, 2022
Ritika has also extensively worked with clients such as WHO, GAVI Alliance, USAID, Gilead, Novartis, Sanofi Pasteur
